Breakthrough 3D X-ray Scan Sheds New Light on Deadly Lung Disease
Scientists at the University of Southampton have used cutting-edge 3D X-ray imaging to crack open the mystery of a killer lung condition. For the first time, the team applied advanced Microfocus CT technology—normally reserved for inspecting jet engine parts—to scan lung tissue from patients with Idiopathic Pulmonary Fibrosis (IPF).
3D Imaging Revolutionises Lung Disease Diagnosis
IPF is a brutal disease that causes relentless scarring inside the lungs, making it harder to breathe with a tragic life expectancy of just three to five years. Until now, diagnosis relied on traditional CT scans or looking at tissue under a microscope. But Southampton researchers have taken it a step further by capturing detailed 3D images of lung biopsy samples, giving doctors a revolutionary new view of the disease.
Multiple Scarring Sites, Not Just One Wave
Previously, experts believed IPF scarred the lungs in a single sweeping wave from the outside inward. The new study, published in JCI Insight, flips that idea on its head. Instead, it reveals dozens of individual hotspots where scarring is actively developing. This fresh insight could help pinpoint treatments directly where the damage happens.
Hope for Better Treatments and Diagnosis
Dr Mark Jones, lead researcher and Wellcome Trust fellow, said: “This advance is very exciting. For the first time, we can view lung samples in 3D, which could transform how we diagnose and treat IPF. Understanding exactly how scarring happens gives us a fighting chance to develop better, targeted therapies.”
With over 5,000 new IPF cases diagnosed annually in the UK—and rising by 5% a year—this breakthrough couldn’t come soon enough.
From Jet Engines to Human Lungs
The powerful Microfocus CT scanner rotates 360 degrees, snapping thousands of images to build a detailed 3D picture. Professor Ian Sinclair, Director of Southampton’s µ-VIS Centre for Computed Tomography, explains: “Our centre usually inspects everything from aircraft components to plant roots. Applying this tech to human lung tissue is a game changer, with huge potential to bring lab discoveries straight to patient care.”
The project received funding from the Wellcome Trust and involved experts from Royal Brompton Hospital, National Jewish Health in Colorado, and University College London. Ongoing support comes from the Engineering and Physical Sciences Research Council and Nikon Metrology.
The Southampton team is now focused on using this pioneering technique to improve diagnosis and ensure every IPF patient gets the right treatment, faster.
